Patent details

Basic Information

Publication number:

EP3530673

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181818998

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR

French Title of Invention:

ANTAGONISTES ANTI-BÉTA 7 HUMANISÉS ET UTILISATIONS ASSOCIÉES

German Title of Invention:

HUMANISIERTE ANTI-BETA-7-ANTAGONISTEN UND DEREN VERWENDUNG

SPC Number:

Dates

Filing date:

02/09/2005

Grant date:

30/03/2022

EP Publication Date:

28/08/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/03/2022

EP B1 Publication Date:

30/03/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/09/2022

Expiration date:

02/09/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/03/2022

 

 

Name:

Genentech, Inc.

Address:

1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Inventor

1

Name:

DENNIS, Mark, S.

Address:

United States (US)

2

Name:

FONG, Sherman

Address:

United States (US)

Priority

Priority Number:

607377 P

Priority Date:

03/09/2004

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28; A61K 39/395; C07K 16/18; A61P 1/00; A61P 1/04; A61P 3/10; A61P 5/00; A61P 11/06; A61P 29/00; A61P 37/00; A61P 37/06; A61P 41/00; A61P 43/00;

Publication

European Patent Bulletin

Issue number:

202213

Publication date:

30/03/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages